Elevated levels of telomerase activity in malignant pheochromocytoma

Cancer

Volumn 82, Issue 1, 1998, Pages 176-179

  Kubota, Yoko ^a   Nakada, Teruhiro ^a   Sasagawa, Isoji ^a   Yanai, Hiroshi ^a   Itoh, Keichi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Adrenal medulla; Malignant pheochromocytoma; Pheochromocytoma; Telomerase

Indexed keywords

TELOMERASE;

ADRENAL MEDULLA; ADULT; ANEUPLOIDY; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MALE; PHEOCHROMOCYTOMA; PLOIDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADRENAL GLAND NEOPLASMS; ADRENAL MEDULLA; ANEUPLOIDY; BLOOD PRESSURE; CATECHOLAMINES; DNA, NEOPLASM; FEMALE; FLUORESCENCE; FOLLOW-UP STUDIES; FORECASTING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MUTATION; PHEOCHROMOCYTOMA; PLOIDIES; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031941920     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980101)82:1<176::AID-CNCR22>3.0.CO;2-Z     Document Type: Article

References (23)

1. Matsumoto M, Uekado Y, Fonseca E, Ghillani PP, Aubert B, Travagli JP, et al. Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. J Endocrinol Invest 1992;15:631-42.
2. Schlumberger M, Gicquel C, Lumbroso J, Tenenbaum F, Comoy E, Bosq J. High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991. J Endocrinol Invest 1992;15:651-63.
3. Nakada T, Kubota Y, Sasagawa I, Yagisawa T, Watanabe M, Ishigooka M. Remarkably suppressed manganese superoxide dismutase activity in malignant pheochromocytoma. J Urol 1995;153:1787-90.
4. Sasagawa I, Nakada T, Kubota Y, Ishigooka M, Sawamura T, Suzuki Y. Nuclear DNA ploidy pattern and tissue levels of dihydrophenylalanine and catecholamines in pheochromocytoma. Urol Int 1995;54:181-3.
5. Hosaka Y, Rainwater LM, Grant CS, Farrow GM, van Heerden JA, Lieber MM. Pheochromocytoma: nuclear deoxyribonucleic acid patterns studied by flow cytometry. Surgery 1986;100:1003-10.
6. Amberson JB, Vaughan ED Jr., Gray GF, Naus GJ. Flow cytometric determination of nuclear DNA content in benign adrenal pheochromocytomas. Urology 1987;30:102-4.
7. Klein FA, Kay S, Ratliff JE, White FK, Newsome HH. Flow cytometric determinations of ploidy and proliferation patterns of adrenal neoplasms: an adjunct to histological classification. J Urol 1985;134:862-6.
8. Lin SR, Lee YJ, Tsai JH. Mutations of the p53 gene in human functional adrenal neoplasms. J Clin Endocrinol Metab 1994;78:483-91.
9. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979;282:615-6.
10. Kim NW, Piatyszed MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5.
11. Blackburn EH. Telomerases. Annu Rev Biochem 1992; 61:113-29.
12. Zakian VA. Structure and function of telomeres. Annu Rev Genet 1989;23:579-604.
13. Watson JD. Origin of concatemeric T7 DNA. Nature New Biol 1972;239:197-201.
14. Olovnikov AM. A theory of marginotomy. J Theor Biol 1973;41:181-90.
15. Levy MZ, Allsopp RC, Jutcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992;225:951-60.
16. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-60.
17. Allsopp RC, Vaziri H, Patterson C, Glodstein S, Younglai E, Jutcher B, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89:10114-8.
18. Counter CM, Avillion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, et al. Telomerase shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
19. de Lange T. Activation of telomerase in human tumor. Proc Natl Acad Sci USA 1994;91:2882-5.
20. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995;1:249-55.
21. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55:2533-6.
22. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3255-62.
23. Yu GL, Bradley JD, Attardi LD, Blackburn EH. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 1990;344:126-32.